Clinical Trials Logo

Clinical Trial Summary

This trial will test if adding nitric oxide (NO) gas to the cardiopulmonary bypass (CPB) circuit in infants undergoing an arterial switch operation (ASO) for Transposition of the Great Arteries (TGA) changes the incidence of major postoperative adverse events (AEs). Major postoperative AEs include cardiac arrest, emergency chest opening, use of ECMO (machine that acts as an artificial heart and lung during surgery), and death. Participants will be randomised to receive oxygen plus nitric oxide (intervention arm) or oxygen without nitric oxide (control arm) during CPB.


Clinical Trial Description

The incidence of congenital heart disease (CHD) is approximately 1/100 live born children, of which up to 50% require cardiac surgery to correct the underlying abnormality at some stage during their life. (Centre for Disease Control and Prevention, USA). Despite major improvements in CPB devices, the exposure of host blood to large artificial organ surfaces, combined with myocardial injury during planned myocardial ischemia, results in a significant systemic inflammatory response. CPB-triggered systemic inflammatory syndrome is responsible for the most serious and potentially life-threatening side effects associated with cardiac surgery. It is characterized by endotoxin release, leukocyte and complement activation, and widespread activation of inflammatory mediators, resulting in endothelial leak, increased oxygen consumption, and organ dysfunction. NO is an endogenous anti-inflammatory mediator that helps to protect endothelial beds and immunologically active cells. NO has a myocardial protective effect by reducing reperfusion injury. NO generation is essential for regulation of endothelial function and microvascular inflammation. However, dysregulation of endogenous NO during CPB may aggravate the subsequent inflammatory response. A randomized controlled study adding NO into the bypass circuit was conducted by the Royal Children's Hospital in Melbourne on 198 children. This pilot study confirmed the positive effects of gaseous NO reported in the U.S. trial, as well as a reduction in the incidence of low cardiac output syndrome (LCOS). Other improved patient outcomes included a reduced need for extracorporeal life support (ECLS), trends towards a reduced length of stay, and shorter duration of ventilation. In light of these promising preliminary results from these two separate studies, a large multicentre trial to test these findings in children requiring cardiac surgery is needed. The NASO study is running concurrently with the Nitric Oxide during Cardio Pulmonary Bypass during surgery for congenital heart defects: A Randomised Controlled Trial study (ANZCTR Trial Registry ID: ACTRN12617000821392) within Australia (run by Lady Cilento, Brisbane). This study is aiming to look at the effects of Nitric Oxide on all children under the age of 2 years undergoing bypass surgery for CHD. TGA presents in 5-7% of all patients with congenital heart disease and isolated TGA is managed in a similar manner all over the world. The surgical treatment for this is the ASO. Hence this single operation and diagnosis provides an appropriate setting to evaluate the efficacy of NO in the CPB circuit. By allowing each centre to have their own protocols of care (pre, intra and postoperatively) and only collecting 'routine clinical data", the investigators anticipate each centre having high rates of screening and consent. Patients will be stratified by centre and by age at time of surgery. Participants will be randomized into one of two arms: - Intervention arm will receive NO 20 parts per million (ppm) into the oxygenator of a cardio-pulmonary bypass circuit - Control arm will not receive NO At the end of CPB, the participants will return to the Intensive Care Unit where normal care will continue. A total of 800 participants will be enrolled in the study and will be stratified by centre and age at time of surgery. Study aims to investigate whether exposure to gaseous NO reduces the incidence of postoperative major adverse events in infants on cardiopulmonary bypass. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03661385
Study type Interventional
Source Murdoch Childrens Research Institute
Contact
Status Completed
Phase Phase 3
Start date July 11, 2018
Completion date April 23, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05524324 - Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT N/A
Recruiting NCT04616222 - A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels
Completed NCT03833843 - Sudden Cardiac Death in Systemic Right Ventricle
Active, not recruiting NCT02588989 - Fibrosis, Valvular and Ventricular Function in Patients With TGA
Recruiting NCT04106479 - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Active, not recruiting NCT04335448 - Comprehensive Long-term Follow up of Adults With Arterial Switch Operation
Completed NCT01916499 - MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries N/A
Recruiting NCT05452720 - MASA Valve Early Feasibility Study N/A
Completed NCT03078413 - Late Function After Surgery for Transposition of the Great Arteries
Completed NCT00199771 - Hypertonic Saline Dextran in Pediatric Cardiac Surgery Phase 2
Completed NCT00703352 - Eplerenone in Systemic Right Ventricle Phase 4
Completed NCT00006183 - Comparison of Hematocrit Levels in Infant Heart Surgery Phase 3
Completed NCT00005190 - Reproduction and Survival After Cardiac Defect Repair N/A
Completed NCT00837603 - Physical Training in Transposition of the Great Arteries N/A
Completed NCT00374088 - N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) Phase 2
Completed NCT00000470 - Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Phase 3
Completed NCT05160116 - Influence of Timing of Switch Operation in Transposition of Great Arteries
Completed NCT05089773 - Outcomes of Transposition of the Great Arteries After Arterial Switch Operation
Recruiting NCT05809310 - Effects Branch PA Stenting d-TGA, ToF and TA N/A
Not yet recruiting NCT04288596 - Canadian Adult Congenital Heart Disease Intervention Registry